LA-NSCLC:-

Huei-Tyng Huang1

  • 1Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.

概括

优化化疗 (CRT) 与免疫检查点阻塞 (ICB) 显示了肺癌的有希望的生存率. 心脏节约技术进一步提高整体存活率 (OS),而质子疗法提供了额外的好处.